Technimark Adds-On with Rage Buy

Technimark, a portfolio company of Oak Hill Capital and Pritzker Private Capital, has acquired Rage Custom Plastics, a manufacturer of plastic products used in medical and consumer healthcare applications.

Rage Custom Plastics manufactures injection-molded and injection blow-molded plastic components, including plastic bottles, containers, and specialized molded parts used in medical devices, pharmaceutical packaging, and consumer healthcare products. The company also provides product development services and manufacturing programs for customers seeking specialized packaging and molded components.

Rage was founded in 1961 by Nick Saliaris and today is led by his son, CEO Dan Saliaris. The company is headquartered near Columbus in Hilliard, Ohio, and operates an additional facility in Ohio and two in Virginia.

“My father started Rage 65 years ago with a simple belief,” said Mr. Saliaris. “Take care of your people, do right by your customers, and the business will take care of itself. Technimark’s values, culture, and long-term vision mirror our own, and they bring capabilities and global scale that will create tremendous opportunity for our employees and customers. I feel incredibly proud of what we’ve built — and confident that Rage’s legacy will be even stronger as part of Technimark.”

Technimark manufactures rigid plastic packaging and components that are used in the consumer packaged goods, healthcare, and specialty industrial markets. The company’s products include injection-molded containers, closures, dispensers, and medical device components. Technimark’s packaging systems are used for personal care, food and beverages, and over-the-counter pharmaceuticals. Its healthcare segment provides components for drug delivery devices and diagnostic equipment.

Technimark was founded in 1983 and is headquartered in Asheboro, North Carolina, with additional manufacturing facilities in Pennsylvania, Texas, West Virginia, Mexico, Europe, and China.

“Rage’s talented team, strong culture, and long-term partnerships with strategic healthcare customers make them a perfect acquisition for us. We are excited to welcome the Rage team to the Technimark global organization and look forward to building a stronger future together as we continue advancing our mission to make what makes life better,” said Kris Peavy, chief commercial officer and president of healthcare at Technimark.

Pritzker Private Capital acquired Technimark in 2014 from Quad-C Management and sold a majority interest in the company to Oak Hill Capital in 2021. The acquisition of Rage is the first add-on acquisition for Technimark under Oak Hill ownership.

Over its 40-year history, middle-market-focused Oak Hill Capital has invested in over 115 companies and has raised over $25 billion of capital. The firm is currently raising its seventh flagship fund with a target of $3.75 billion to $5.5 billion. Oak Hill began its investment activities in 1986 as the family office of Robert M. Bass and today has offices in New York City, Menlo Park, and Stamford.

Pritzker Private Capital invests in North America-based middle-market companies that have enterprise values between $200 million and $2 billion and EBITDA of more than $15 million. Sectors of interest include manufactured products and services. The firm targets equity investments between $100 million and $400 million, with the ability to invest up to $750 million per transaction. The Chicago-based firm is led by CEO Tony Pritzker and closed its oversubscribed fourth fund, PPC Fund IV LP, with $3.4 billion in August 2025.